Covis acquires U.S. rights to five GSK drugs

GSK to retain rights outside United States
December 22, 2011
A Swiss drug maker is acquiring the U.S. rights for several GlaxoSmithKline drugs.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>
Related Terms:
Branded
Pharmacist Society
Collaborative Care
Supplier News
Latest News
Pharmacy
Covis Pharma Sarl
GlaxoSmithKline
Switzerland
Acquisition
Antidepressant
Ceftazidime
Cefuroxime
Digoxin
Furans
GlaxoSmithKline
Pharmaceutical companies
Pharmaceutical industry
Ranitidine
U.S.
© 2012 Drug Store News. All Rights Reserved.